Testing effectiveness (Phase 2)Study completedNCT00943540
What this trial is testing
Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients
Who this might be right for
HIV InfectionHIV Infections
Radboud University Medical Center 20